
Commentary|Articles|December 9, 2024
ACNP Meeting Highlights Bright Future for Psychiatry
Author(s)Steven P. Levine, MD, Heidi Anne Duerr, MPH
In highlighting recent advances and fostering collaboration and networking, the ACNP Annual Meeting helps usher in 2025 with hope and positivity.
Advertisement
CONFERENCE REPORTER
Psychiatric Times sat down with Steve Levine, MD, psychiatrist and senior vice president of Patient Access and Medical Affairs at Compass Pathways to discuss the 63rd Annual Meeting of the American College of Neuropsychopharmacology, the latest advances in psychiatry, and the reasons the field can be hopeful as we look toward 2025.
Did you attend the ACNP Annual Meeting? What were your highlights? Share your thoughts with us via [email protected]
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
New 6-Month Data From Second Phase 3 Trial Confirms Rapid Effect of COMP360 for TRD
2
Filling the Gap Between IV Ketamine Clinical Use and Evidence-Based Standards
3
Expanding ADHD Pharmacology: Pipeline Highlights With Ann Childress, MD
4
Psychedelics, Orexin Blockers, and More: Inside the Diverse New Pipeline for Depression
5











